K. Sliva

发表

Targeting retroviral vector entry by host range extension

B. Schnierle, K. Sliva, 2004 .

Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome.

B. Schnierle, K. Sliva, 2006, Virology.

Expression of human endogenous retrovirus-K coincides with that of micro-RNA-663 and -638 in germ-cell tumor cells.

B. Schnierle, K. Sliva, Benjamin Kraus, 2012, Anticancer research.

Cutaneous T‐cell lymphoma cells are sensitive to rapamycin

C. Klemke, B. Schnierle, K. Sliva, 2010, Experimental dermatology.

Delayed onset of graft‐versus‐host disease in immunodeficent human leucocyte antigen‐DQ8 transgenic, murine major histocompatibility complex class II‐deficient mice repopulated by human peripheral blood mononuclear cells

B. Schnierle, K. Sliva, Z. Waibler, 2013, Clinical and experimental immunology.

From actually toxic to highly specific – novel drugs against poxviruses

B. Schnierle, K. Sliva, 2007, Virology Journal.

The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.

B. Schnierle, K. Sliva, B. Kümmerer, 2015, Antiviral research.

The Cellular Antiviral Restriction Factor Tetherin Does Not Inhibit Poxviral Replication

B. Schnierle, K. Sliva, O. Keppler, 2011, Journal of Virology.

Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.

B. Schnierle, G. Sutter, K. Sliva, 2007, Virus research.

Latest animal models for anti-HIV drug discovery

K. Sliva, 2015, Expert opinion on drug discovery.

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry

B. Schnierle, S. Becker, N. Biedenkopf, 2016, Virology Journal.

Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system

B. Schnierle, K. Sliva, Benjamin Kraus, 2014, Virology Journal.

Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System

R. Löwer, W. Wels, B. Schnierle, 2013, PloS one.

Selective gene silencing by viral delivery of short hairpin RNA

B. Schnierle, K. Sliva, 2010, Virology Journal.

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.

B. Schnierle, G. Sutter, K. Sliva, 2010, Virology.

Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression

B. Schnierle, K. Sliva, M. Toda, 2019, Journal of Virology.

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry

B. Schnierle, S. Becker, N. Biedenkopf, 2016, Virology Journal.

Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.

C. Grimm, R. Müller, B. Schnierle, 2016, Antiviral research.

RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors

K. Cichutek, B. Schnierle, K. Sliva, 2011, Gene Therapy.

Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro.

B. Schnierle, K. Sliva, Christine von Rhein, 2016, Antiviral research.

Murine leukemia virus (MLV) replication monitored with fluorescent proteins

B. Schnierle, K. Sliva, O. Erlwein, 2004, Virology Journal.